Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT05035043
NCT05035043CompletedNot Applicable

The Economic Burden of Non-Alcoholic Fatty Liver Disease Patients in Flanders, Belgium

Hasselt University2 sites in 1 country73 target enrollmentStarted: March 1, 2021Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
73
Locations
2
Primary Endpoint
iMTA MCQ
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

To determine the economic burden of NAFLD (Non-Alcoholic-Fatty-Liver Disease) patients in Belgium, Flanders by means of a bottom-up approach.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •having NAFLD as was diagnosed by FibroScan®,
  • •18 years or older
  • •BMI ≥ 25 kg/m²

Exclusion Criteria

  • •unable to give informed consent
  • •>70 years

Outcomes

Primary Outcomes

iMTA MCQ

Time Frame: baseline

Healthcare cost measured with the iMTA MCQ (Institute for Medical Technology Assessment Medical Consumption Questionnaire). The volumes of used healthcare costs were multiplied with the unit costs of these corresponding services.

Secondary Outcomes

  • EuroQol-5D-5L(baseline)
  • iMTA MCQ(Baseline)

Investigators

Sponsor
Hasselt University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Geert Robaeys

Principal Investigator

Hasselt University

Study Sites (2)

Loading locations...

Similar Trials

Active, not recruiting
Not Applicable
Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 DiabetesNonalcoholic Fatty LiverNonalcoholic SteatohepatitisFibrosis, LiverCirrhosis, LiverType 1 Diabetes
NCT04595474Joslin Diabetes Center533
Not yet recruiting
Not Applicable
Studying Non Alcoholic Fatty Liver Disease and Liver Fibrosis Among Systemic Lupus Erythematosus Patients At Assiut University HospitalNAFLD - Nonalcoholic Fatty Liver Disease
NCT06601361Assiut University112
Active, not recruiting
Not Applicable
Prevalence of NAFLD in T2DM PatientsNAFLDT2DFatty Liver, NonalcoholicType 2 Diabetes
NCT06445335Ziekenhuis Oost-Limburg385
Not yet recruiting
Phase 2
Study of Liver Fibrosis Stage Assessment by Fibroblast Activation Protein Imaging in Patients With Biopsy for Suspected or Proven Nonalcoholic SteatohepatitisNon-alcoholic Steatohepatitis
NCT06160271Central Hospital, Nancy, France72
Unknown
Not Applicable
Clinical Epidemiology of NAFLD in Children and AdolescentsNon-Alcoholic Fatty Liver DiseaseChildhood Obesity
NCT05526274Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina2,866